Efegatran sulphate has no advantage over heparin as an...

Efegatran sulphate has no advantage over heparin as an adjunct to thrombolytic therapy in acute myocardial infarction

Briain D. MacNeill, Ik-Kyung Jang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2002
Language:
english
DOI:
10.1054/ebcm.2002.0499
File:
PDF, 88 KB
english, 2002
Conversion to is in progress
Conversion to is failed